FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1148537007: Tepotinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4550492010 Tepotinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4550493017 Tepotinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tepotinib Is a Antineoplastic agent (substance) false Inferred relationship Some
Tepotinib Is a Piperidine true Inferred relationship Some
Tepotinib Is a Protein-tyrosine kinase inhibitor false Inferred relationship Some
Tepotinib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) false Inferred relationship Some
Tepotinib Is a Enzyme inhibitor false Inferred relationship Some
Tepotinib Is a Mesenchymal epithelial transition inhibitor true Inferred relationship Some
Tepotinib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Mesenchymal epithelial transition inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tepotinib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tepotinib Inferred relationship Some 1
Tepotinib only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tepotinib Inferred relationship Some 1
Tepotinib only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tepotinib Inferred relationship Some 1
Product containing tepotinib in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tepotinib Inferred relationship Some 1
Tepotinib hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tepotinib Inferred relationship Some
Product containing precisely tepotinib (as tepotinib hydrochloride) 225 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tepotinib Inferred relationship Some 1

This concept is not in any reference sets

Back to Start